Oberaegeri, Switzerland

Jon Helge Hoem

This inventor holds 17 USPTO granted patents and 7 published patent applications and 7 EPO patents. Top assignees: Corflow Therapeutics Ag, Miracor Medical Sa, Miracor Medical Systems Gmbh. Active years: 2014-2026.

USPTO Granted Patents = 17 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.6

ph-index = 6

Forward Citations = 79(Granted Patents)


Location History:

  • Oberägeri, CH (2019 - 2021)
  • Oberageri, CH (2021)
  • Oberaegeri, CH (2014 - 2023)
  • Baar, CH (2023 - 2024)

Company Filing History:


Years Active: 2014-2026

Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents

Title: Jon Helge Hoem - Innovative Inventor from Oberaegeri, Switzerland

Introduction: Jon Helge Hoem is a talented inventor hailing from the picturesque town of Oberaegeri, Switzerland. With a passion for creating groundbreaking solutions, he has made significant contributions to the field of innovation.

Latest Patents: Jon Helge Hoem holds several patents in various industries, showcasing his diverse range of expertise and creativity. His latest patents focus on sustainable energy solutions and advanced medical devices.

Career Highlights: Throughout his career, Jon Helge Hoem has been recognized for his innovative thinking and problem-solving skills. He has successfully brought several inventions to market, improving the lives of many individuals around the world.

Collaborations: Jon Helge Hoem has collaborated with leading research institutions and universities to further his inventions. His partnerships have led to the development of cutting-edge technologies that have the potential to shape the future of multiple industries.

Conclusion: Jon Helge Hoem's dedication to innovation and his relentless pursuit of excellence make him a standout figure in the world of inventors. His passion for creating impactful solutions continues to drive his success in the field of patents and inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…